Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol(®) on glycemic control of subjects with impaired fasting glucose.

Diabetes Metab Syndr Obes · 2015 · PMC4485843 · PMID 26150732

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a trend toward significanceP =0.08so close (0.05 < p ≤ 0.1)

The within-group increase in FBG in the placebo group showed a trend toward significance at week 12 (95% CI [−3.3, 51.3]; P =0.08), and reached significance at week 24 (95% CI [0, 46.1]; P =0.05) ( Figure 3A ).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.